News and Announcements
Author-IT Finalizes $13.5m NZ Series C Funding & Releases DocuveraTM
- Published August 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Author-it is a fast growing SaaS business that provides cloud based, authoring and content management solutions, purpose-built for the life sciences industry where documentation accounts for ~25% of the average cost of bringing a drug to market.
This past year was both successful and eventful for Author-it Software Corporation, a world leader in component authoring and content management solutions for the Life Sciences industry. The company finalized a $13.5m NZ Series C funding that had commenced earlier in 2016. In addition, Author-it formally released DocuveraTM in June 2017. Docuvera is a new transformative software platform used to create Life Science documentation for global companies. Docuvera dramatically increases compliance and lowers operating costs by 50%. Lastly, Author-it continued to sign new customers from the top tiers of global Life Sciences companies and add to its considerable and prestigious customer base.
ABOUT AUTHOR-IT
Author-it Software Corporation (ASC) is a world leader in component authoring solutions. We enable the efficient authoring, sharing and reuse of information across a number of content types. Reuse of information drives massive process and content production improvements including increased productivity, reduced time to market, better accuracy and consistency, improved customer experience and substantial cost savings. Author-it solutions have been built in partnership with our clients and are the culmination of more than 20 years component authoring experience.
Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets
QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Backed By Leading Investment Groups and Family Offices
